Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculat